Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.
Chengyuan Li
Advertisement
Articles by Chengyuan Li
Advertisement
Latest Updated Articles
Unlocking PROTACs’ Potential: Overcoming Development ChallengesPublished: February 6th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
FDA Approves 1-Minute HIV Self-Test
4
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
5
